Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€37.03
29.01.21
€34.00
29.04.21
-5.94%
08.02.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€274.60
29.01.21
€300.00
29.01.22
52.59%
30.01.22

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€282.25
28.01.21
€350.00
28.01.22
22.16%
02.07.21

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€38.20
27.01.21
-
27.01.22
8.01%
28.09.21

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€38.44
27.01.21
€45.00
27.01.22
-4.29%
28.01.22

Could be worthwhile Investment >10% per year
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€38.65
26.01.21
-
26.01.22
8.46%
10.09.21

Atossa Genetics Inc

Start price
Target price
Perf. (%)
€3.08
26.01.21
-
-46.41%
28.01.21

Could be very worthwhile Investment >20% year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€240.00
25.01.21
€350.00
25.01.22
-73.33%
26.01.22

Could be very worthwhile Investment >20% year
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€37.69
25.01.21
-
25.01.22
-3.52%
26.01.22

buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.86
25.01.21
€1.00
25.01.22
-80.01%
24.01.22

Could be worthwhile Investment >10% per year
buy
Biosynex

Start price
Target price
Perf. (%)
€21.20
25.01.21
€26.00
25.01.22
-26.13%
20.10.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€2.10
25.01.21
€3.00
25.01.22
63.56%
08.02.21

Could be worthwhile Investment >10% per year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.16
25.01.21
€4.00
25.01.22
-1.27%
08.02.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€36.75
25.01.21
€50.00
25.01.22
-12.24%
08.02.21

Could be worthwhile Investment >10% per year
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€7.55
25.01.21
€10.00
25.01.22
-2.65%
08.02.21

Could be very worthwhile Investment >20% year
buy
Tandem Diabetes Care Inc

Start price
Target price
Perf. (%)
€81.19
24.01.21
€140.00
24.01.22
30.56%
15.01.22

buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€71.80
24.01.21
€90.00
24.01.22
-32.37%
25.01.22

buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€1.85
23.01.21
€60.00
23.01.22
-41.51%
24.01.22

Could be very worthwhile Investment >20% year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.16
23.01.21
€30.00
23.01.22
-67.09%
24.01.22

Could be very worthwhile Investment >20% year
buy
BioLase Inc.

Start price
Target price
Perf. (%)
€22.13
23.01.21
€200.00
23.01.22
-66.09%
24.01.22

buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€35.75
23.01.21
-
23.01.22
-73.67%
24.01.22

Could be very worthwhile Investment >20% year
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€55.30
23.01.21
-
23.01.22
100.72%
13.11.21

buy
Asensus Surgical Inc.

Start price
Target price
Perf. (%)
€3.48
23.01.21
-
23.01.22
-63.22%
19.11.21

buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€67.80
23.01.21
€88.00
23.01.22
-26.99%
24.01.22

Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€71.80
23.01.21
€88.00
23.01.22
-30.36%
24.01.22

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected